Monday, January 10, 2022 7:58:13 PM
https://www.marketwatch.com/story/bone-biologics-up-82-on-conference-presentation-271641843405
Recent BBLG News
- Bone Biologics Announces Closing of $2.0 Million Public Offering • Business Wire • 03/06/2024 09:15:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/05/2024 05:15:24 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 03/04/2024 10:21:24 PM
- Bone Biologics Announces Pricing of $2.0 Million Public Offering • Business Wire • 03/04/2024 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:05:30 PM
- Bone Biologics Reports Progress With NB1 Clinical Program • Business Wire • 03/01/2024 01:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/26/2024 09:50:51 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/23/2024 10:09:17 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/21/2024 10:05:59 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:41:42 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 03:55:05 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:03:32 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2024 10:09:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 10:24:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 10:22:54 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/17/2024 10:21:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 10:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 01:15:18 PM
- Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors • Business Wire • 01/11/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:17:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 01:15:12 PM
- Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements • Business Wire • 01/10/2024 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/05/2024 10:15:59 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM